DELCATH SYSTEMS, INC. (DCTH) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income $2.40M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$1.64M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$388.00K; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income $2.59M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | $2.40M | (m) | $29.13M | (m) | $503.00K* | $5.71M* | (m) | $10.38M | $13.37M | $491.00K |
| 2026-03-31 | Reported | (m) | -$1.64M | (m) | $24.99M | (m) | $570.00K | $857.00K | (m) | $9.82M | $13.07M | $162.00K |
| 2025-09-30 | Reported | (m) | -$388.00K | (m) | $20.56M | (m) | $459.00K* | $4.77M* | (m) | $7.99M | $10.34M | -$455.00K |
| 2025-06-30 | Reported | (m) | $2.59M | (m) | $24.16M | (m) | $398.00K* | $7.29M* | (m) | $6.88M | $11.37M | $508.00K |
| 2025-03-31 | Reported | (m) | $642.00K | (m) | $19.78M | (m) | $140.00K | $2.20M | (m) | $5.01M | $11.29M | $195.00K |
| 2024-09-30 | Reported | (m) | -$1.26M | (m) | $11.20M | (m) | $216.00K* | -$3.64M* | (m) | $3.87M | $6.95M | $0.00 |
| 2024-06-30 | Reported | (m) | -$3.91M | (m) | $7.77M | (m) | $101.00K* | -$4.45M* | (m) | $3.39M | $6.76M | $0.00 |
| 2024-03-31 | Reported | (m) | -$10.28M | (m) | $3.14M | (m) | $13.00K | -$9.58M | (m) | $3.70M | $8.81M | $0.00 |
| 2023-09-30 | Reported | (m) | -$10.56M | (m) | $434.00K | (m) | -$1.00K* | -$9.16M* | (m) | $4.66M | $6.20M | (m) |
| 2023-06-30 | Reported | (m) | -$8.00M | (m) | $495.00K | (m) | $40.00K* | -$9.65M* | (m) | $3.56M | $4.79M | (m) |
| 2023-03-31 | Reported | (m) | -$8.32M | (m) | $597.00K | (m) | $0.00 | -$4.26M | (m) | $4.58M | $4.17M | (m) |
| 2022-09-30 | Reported | (m) | -$8.17M | (m) | $906.00K | (m) | $68.00K* | -$5.18M* | (m) | $4.07M | $4.78M | (m) |
| 2022-06-30 | Reported | (m) | -$9.49M | (m) | $797.00K | (m) | $52.00K* | -$6.04M* | (m) | $5.61M | $4.50M | (m) |
| 2022-03-31 | Reported | (m) | -$8.34M | (m) | $378.00K | (m) | $89.00K | -$6.38M | (m) | $4.48M | $4.20M | (m) |
| 2021-09-30 | Reported | (m) | -$6.70M | (m) | (m) | (m) | $56.00K* | -$4.91M* | (m) | $2.96M | $4.04M | (m) |
| 2021-06-30 | Reported | (m) | -$6.45M | (m) | (m) | (m) | $79.00K* | -$7.10M* | (m) | $3.50M | $3.29M | (m) |
| 2021-03-31 | Reported | (m) | -$6.73M | (m) | (m) | (m) | $9.00K | -$4.57M | (m) | $3.71M | $3.30M | (m) |
| 2020-09-30 | Reported | (m) | -$4.98M | (m) | (m) | (m) | $487.00K* | -$4.75M* | (m) | $3.26M | $2.00M | (m) |
| 2020-06-30 | Reported | (m) | -$4.27M | (m) | (m) | (m) | $41.00K* | -$7.85M* | (m) | $2.22M | $2.26M | (m) |
| 2020-03-31 | Reported | (m) | -$5.07M | (m) | (m) | (m) | $180.00K | -$5.23M | (m) | $2.97M | $2.32M | (m) |
| 2019-09-30 | Reported | (m) | -$5.57M | (m) | (m) | (m) | $0.00* | -$12.36M* | (m) | $1.78M | $4.00M | (m) |
| 2019-06-30 | Reported | (m) | -$4.13M | (m) | (m) | (m) | $0.00* | -$3.19M* | (m) | $1.71M | $2.65M | (m) |
| 2019-03-31 | Reported | (m) | -$5.67M | (m) | (m) | (m) | $2.00K | -$2.77M | (m) | $3.30M | $2.55M | (m) |
| 2018-09-30 | Reported | (m) | -$5.79M | (m) | $824.00K | (m) | $20.00K* | -$3.62M* | (m) | $4.11M | $2.28M | (m) |
| 2018-06-30 | Reported | (m) | -$6.09M | (m) | $858.00K | (m) | $33.00K* | -$2.83M* | (m) | $4.09M | $2.64M | (m) |
| 2018-03-31 | Reported | (m) | -$7.50M | (m) | (m) | (m) | $6.00K | -$6.44M | (m) | $5.69M | $2.37M | (m) |
| 2017-12-31 | Reported | (m) | -$4.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | Reported | (m) | -$4.63M | (m) | $684.00K | (m) | $96.00K* | -$3.52M* | (m) | $2.28M | $2.86M | (m) |
| 2017-06-30 | Reported | (m) | -$4.60M | (m) | $584.00K | (m) | $218.00K* | (m) | (m) | $2.52M | $2.53M | (m) |
| 2017-03-31 | Reported | (m) | -$4.21M | (m) | (m) | (m) | $58.00K | (m) | (m) | $2.32M | $2.42M | (m) |
| 2016-12-31 | Reported | (m) | -$4.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | Reported | (m) | -$4.72M | (m) | (m) | (m) | $150.00K* | (m) | (m) | $2.69M | $2.36M | (m) |
| 2016-06-30 | Reported | (m) | -$3.87M | (m) | (m) | (m) | $80.00K* | (m) | (m) | $1.95M | $2.29M | (m) |
| 2016-03-31 | Reported | (m) | -$3.46M | (m) | (m) | (m) | $15.00K | (m) | (m) | $1.34M | $2.38M | (m) |
| 2015-12-31 | Reported | (m) | -$4.23M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | Reported | (m) | -$3.65M | (m) | (m) | (m) | $42.00K* | (m) | (m) | $1.68M | $2.28M | (m) |
| 2015-06-30 | Reported | (m) | -$3.62M | (m) | (m) | (m) | $42.00K* | (m) | (m) | $1.45M | $2.50M | (m) |
| 2015-03-31 | Reported | (m) | -$3.71M | (m) | (m) | (m) | $45.00K | (m) | (m) | $979.00K | $3.04M | (m) |
| 2014-12-31 | Reported | (m) | -$3.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | Reported | (m) | -$5.05M | (m) | (m) | (m) | $0.00* | (m) | (m) | $683.00K | $4.54M | (m) |
| 2014-06-30 | Reported | (m) | -$5.90M | (m) | (m) | (m) | $0.00* | -$4.00M* | (m) | $1.49M | $4.60M | (m) |
| 2014-03-31 | Reported | (m) | -$5.06M | (m) | (m) | (m) | $0.00 | -$4.49M | (m) | $1.46M | $3.82M | (m) |
| 2013-12-31 | Reported | (m) | -$5.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | Reported | (m) | -$6.70M | (m) | (m) | (m) | $34.00K* | -$7.40M* | (m) | $2.18M | $4.57M | (m) |
| 2013-06-30 | Reported | (m) | -$10.59M | (m) | (m) | (m) | $45.00K* | -$10.56M* | (m) | $3.99M | $6.26M | (m) |
| 2013-03-31 | Reported | (m) | -$10.20M | (m) | (m) | (m) | $34.00K | -$10.94M | (m) | $4.47M | $6.08M | (m) |
| 2012-12-31 | Reported | (m) | -$11.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | Reported | (m) | -$12.18M | (m) | (m) | (m) | $824.00K* | -$13.46M* | (m) | $5.25M | $6.96M | (m) |
| 2012-06-30 | Reported | (m) | -$15.32M | (m) | (m) | (m) | $680.00K* | -$13.01M* | (m) | $8.20M | $7.22M | (m) |
| 2012-03-31 | Reported | (m) | -$14.55M | (m) | (m) | (m) | $572.00K | -$14.18M | (m) | $7.13M | $7.42M | (m) |
| 2011-12-31 | Reported | (m) | $15.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | Reported | (m) | $12.18M | (m) | (m) | (m) | $396.00K* | -$9.55M* | (m) | $6.44M | $5.74M | (m) |
| 2011-09-30 | Reported | (m) | -$12.18M | (m) | (m) | (m) | (m) | (m) | (m) | $6.44M | (m) | (m) |
| 2011-06-30 | Reported | (m) | $10.49M | (m) | (m) | (m) | $630.00K* | -$7.54M* | (m) | $5.25M | $5.24M | (m) |
| 2011-03-31 | Reported | (m) | $7.81M | (m) | (m) | (m) | $1.25M | -$6.72M | (m) | $3.65M | (m) | (m) |
| 2010-09-30 | Reported | (m) | -$7.42M | (m) | (m) | (m) | $377.65K* | -$6.01M* | (m) | $4.26M | (m) | (m) |
| 2010-06-30 | Reported | (m) | -$8.31M | (m) | (m) | (m) | (m) | (m) | (m) | $4.60M | (m) | (m) |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | $660.00K | (m) | $85.23M | (m) | $1.55M | $22.52M | (m) | $29.25M | $43.53M | $810.00K |
| 2024-12-31 | Reported | (m) | -$12.41M | (m) | $37.20M | (m) | $559.00K | -$18.68M | (m) | $13.87M | $29.55M | $0.00 |
| 2023-12-31 | Reported | (m) | -$38.18M | (m) | $2.06M | (m) | $58.00K | -$31.25M | (m) | $17.50M | $22.11M | $0.00 |
| 2022-12-31 | Reported | (m) | -$33.85M | (m) | $2.72M | (m) | $209.00K | -$24.95M | (m) | $18.58M | $17.30M | $0.00 |
| 2021-12-31 | Reported | (m) | -$24.53M | (m) | $3.56M | (m) | $143.00K | -$22.60M | (m) | $13.78M | $13.64M | $0.00 |
| 2020-12-31 | Reported | (m) | -$21.30M | (m) | (m) | (m) | $782.00K | -$22.87M | (m) | $11.20M | $11.11M | $0.00 |
| 2019-12-31 | Reported | (m) | -$19.91M | (m) | (m) | (m) | $24.00K | -$23.69M | (m) | $9.49M | $11.28M | $0.00 |
| 2018-12-31 | Reported | (m) | -$27.07M | (m) | (m) | (m) | $76.00K | -$14.73M | (m) | $19.65M | $9.82M | $0.00 |
| 2018-09-30 | Rolling | (m) | -$24.11M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | Rolling | (m) | -$22.95M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | Rolling | (m) | -$21.46M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | Reported | (m) | -$18.16M | (m) | (m) | (m) | $524.00K | -$15.40M | (m) | $10.49M | $9.68M | $0.00 |
| 2017-12-31 | Rolling | (m) | -$18.16M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | Rolling | (m) | -$17.82M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | Rolling | (m) | -$17.92M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | Rolling | (m) | -$17.19M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | Reported | (m) | -$16.44M | (m) | (m) | (m) | $258.00K | (m) | (m) | $8.45M | $9.43M | $0.00 |
| 2016-12-31 | Rolling | (m) | -$16.44M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | Rolling | (m) | -$16.29M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | Rolling | (m) | -$15.21M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | Rolling | (m) | -$14.96M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | Reported | (m) | -$15.21M | (m) | (m) | (m) | $170.00K | (m) | (m) | $6.49M | $10.01M | $0.00 |
| 2015-12-31 | Rolling | (m) | -$15.21M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | Rolling | (m) | -$14.27M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | Rolling | (m) | -$15.67M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | Rolling | (m) | -$17.95M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | Reported | (m) | -$19.30M | (m) | (m) | (m) | $44.00K | (m) | (m) | $4.30M | $15.78M | $0.00 |
| 2014-12-31 | Rolling | (m) | -$19.30M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | Rolling | (m) | -$21.54M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | Rolling | (m) | -$23.19M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | Rolling | (m) | -$27.87M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | Reported | (m) | -$33.02M | (m) | (m) | (m) | $142.00K | -$34.10M | (m) | $12.69M | $20.66M | $0.00 |
| 2013-12-31 | Rolling | (m) | -$33.02M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | Rolling | (m) | -$39.32M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | Rolling | (m) | -$44.79M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | Rolling | (m) | -$49.52M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | Reported | (m) | -$53.87M | (m) | (m) | (m) | $2.12M | -$50.01M | (m) | $26.21M | $27.96M | $0.00 |
| 2012-12-31 | Rolling | (m) | -$53.87M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | Rolling | (m) | -$26.07M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | Reported | (m) | -$46.46M | (m) | (m) | (m) | $2.61M | -$37.37M | (m) | $25.17M | $21.28M | (m) |
| 2010-12-31 | Reported | (m) | -$30.74M | (m) | (m) | (m) | $1.64M | -$24.08M | (m) | $17.56M | $13.19M | (m) |
| 2009-12-31 | Reported | (m) | -$13.54M | (m) | (m) | (m) | $515.00K | -$10.46M | (m) | $9.64M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| CARLSMED, INC. (CARL) | United States | $0.405B |